RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCIE SSCI SCOPUS KCI등재

      Plasma Brain-Derived Neurotrophic Factor as a Candidate Bio-Marker of the Neuroplastic Changes Related with Fluoxetine Administration in Major Depressive Disorder

      한글로보기

      https://www.riss.kr/link?id=A105324711

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective: The aim of this study was to investigate whether plasma brain-derived neurotrophic factor (BDNF) could be a biological marker related to the pathophysiology of depression and the action mechanism of antidepressants in patients with major de...

      Objective: The aim of this study was to investigate whether plasma brain-derived neurotrophic factor (BDNF) could be a biological marker related to the pathophysiology of depression and the action mechanism of antidepressants in patients with major depressive disorder (MDD).

      Methods and Materials: Forty-nine patients with MDD and 34 normal controls were recruited and analyzed for this study. The severity of depression was measured using the 17-item Hamilton Rating Scale for Depression (HAM-D-17) for MDD patients before and after a 6-week treatment with the antidepressant, fluoxetine. A minimum baseline HAM-D-17 score of
      15 was required for study inclusion. The plasma BDNF was measured in all subjects at baseline and after the 6-week treatment (for the patients). Treatment outcome was measured as response ( ≥50% improvement on HAM-D-17) and remission
      (final HAM-D-17 score≤ 7).

      Results: There were no significant differences in age and gender distribution, or in baseline plasma BDNF, between the MDD and control groups. The severity of depression and plasma BDNF level at baseline were not significantly correlated. There was no significant change in the plasma BDNF of the MDD group after the 6-week treatment, although a modest trend to decrease was noted (Wilcoxon’s signed rank test, S= -186.5, p=0.0629). In addition, there was no significant difference in the change of plasma BDNF between responders and non-responders.

      Conclusions: The findings of this study do not support the proposed hypothesis that plasma BDNF plays a significant
      role as a biological marker in reflecting the neuroplastic change related to the short-term effect of antidepressants
      in MDD. Nevertheless, the possibility of false negative findings suggests that further studies are necessary to replicate the findings.

      더보기

      목차 (Table of Contents)

      • Introduction
      • Methods and Materials
      • Results
      • Discussion
      • Acknowledgements
      • Introduction
      • Methods and Materials
      • Results
      • Discussion
      • Acknowledgements
      • References
      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼